Faes Farma (Faes Farma) Debt-to-Equity : N/A (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Faes Farma Debt-to-Equity?

Faes Farma's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.00 Mil. Faes Farma's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.00 Mil. Faes Farma's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $0.00 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Faes Farma's Debt-to-Equity or its related term are showing as below:

FSXMF' s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.03 Max: 0.16
Current: 0.04

During the past 13 years, the highest Debt-to-Equity Ratio of Faes Farma was 0.16. The lowest was 0.00. And the median was 0.03.

FSXMF's Debt-to-Equity is ranked better than
84.14% of 845 companies
in the Drug Manufacturers industry
Industry Median: 0.3 vs FSXMF: 0.04

Faes Farma Debt-to-Equity Historical Data

The historical data trend for Faes Farma's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Faes Farma Debt-to-Equity Chart

Faes Farma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.04

0.03

0.05

0.04

Faes Farma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															0.05	N/A	0.01	0.04	N/A

Competitive Comparison of Faes Farma's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Faes Farma's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Faes Farma's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Faes Farma's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Faes Farma's Debt-to-Equity falls into.

Faes Farma Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Faes Farma's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(21.29	+	4.769)	/	722.306
	=	0.04

Faes Farma's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	0
	=	N/A

Faes Farma (OTCPK:FSXMF) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Faes Farma Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Faes Farma's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Faes Farma (Faes Farma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Faes Farma SA (OTCPK:FSXMF) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

0K9H:UK FAE:Spain FFEA:Germany

Address

Maximo Aguirre, 14, Leioa, Vizcaya, ESP, 48940

Website

http://www.faes.es

Faes Farma SA is a pharmaceutical company that specializes in the research, production, distribution, and sale of prescription and generic drugs, over-the-counter medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The company develops new drugs for the treatment of allergy, venous insufficiency, and irritable bowel syndrome. It also provides animal nutrition products. Faes Farma exports its products to more than 60 countries and has operations in Spain, Portugal, Chile, and Mexico, among others.

Faes Farma (Faes Farma) Headlines

No Headlines